Antiproliferative activity of human interferons against ovarian cancer cells grown in human tumor stem cell assays

J. K V Willson, G. Bittner, E. C. Borden

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Fresh biopsies from 14 of 22 (64%) ovarian carcinomas cultivated in the human tumor stem cell assay (HTSCA) were sensitive (> 70% inhibition in cell growth) to human interferons (HuIFNs). To achieve 70% inhibition of colony growth, 500 units/ml of a naturally produced IFN-α or IFN-αA were required in 71% of the sensitive specimens. The antiproliferative potencies of five IFNs were evaluated including two native α IFNs, two highly purified cloned subtypes of IFN-α, IFN-αD and IFN-αA, and one native fibroblast-derived beta interferon (IFN-β). The antiviral activity of the IFN-α as determined by a human cell target correlated with their relative antiproliferative action. IFN-αD had minimal inhibitory effect at the highest concentration tested, while three IFN-α with high antiviral activities were equivalent with respect to growth inhibition in the HTSCA. Although instability could not be eliminated as a contributing factor, IFN-β had significantly less growth inhibitory potency for cells from ovarian cancers when compared simultaneously with native IFN-α in the human tumor stem cell assay (HTSCA). Assuming direct antiproliferative effects are primary, future clinical trials evaluating IFN-α in ovarian cancer may require high titers of IFN.

Original languageEnglish (US)
Pages (from-to)441-447
Number of pages7
JournalJournal of Interferon Research
Volume4
Issue number4
StatePublished - 1984

Fingerprint

Tumor Stem Cell Assay
Human Activities
Ovarian Neoplasms
Interferons
Growth
Antiviral Agents
Interferon-beta
Fibroblasts
Clinical Trials
Carcinoma
Biopsy

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Antiproliferative activity of human interferons against ovarian cancer cells grown in human tumor stem cell assays. / Willson, J. K V; Bittner, G.; Borden, E. C.

In: Journal of Interferon Research, Vol. 4, No. 4, 1984, p. 441-447.

Research output: Contribution to journalArticle

@article{0eeeb9ee7e994b11bd3da90d1f6faec7,
title = "Antiproliferative activity of human interferons against ovarian cancer cells grown in human tumor stem cell assays",
abstract = "Fresh biopsies from 14 of 22 (64{\%}) ovarian carcinomas cultivated in the human tumor stem cell assay (HTSCA) were sensitive (> 70{\%} inhibition in cell growth) to human interferons (HuIFNs). To achieve 70{\%} inhibition of colony growth, 500 units/ml of a naturally produced IFN-α or IFN-αA were required in 71{\%} of the sensitive specimens. The antiproliferative potencies of five IFNs were evaluated including two native α IFNs, two highly purified cloned subtypes of IFN-α, IFN-αD and IFN-αA, and one native fibroblast-derived beta interferon (IFN-β). The antiviral activity of the IFN-α as determined by a human cell target correlated with their relative antiproliferative action. IFN-αD had minimal inhibitory effect at the highest concentration tested, while three IFN-α with high antiviral activities were equivalent with respect to growth inhibition in the HTSCA. Although instability could not be eliminated as a contributing factor, IFN-β had significantly less growth inhibitory potency for cells from ovarian cancers when compared simultaneously with native IFN-α in the human tumor stem cell assay (HTSCA). Assuming direct antiproliferative effects are primary, future clinical trials evaluating IFN-α in ovarian cancer may require high titers of IFN.",
author = "Willson, {J. K V} and G. Bittner and Borden, {E. C.}",
year = "1984",
language = "English (US)",
volume = "4",
pages = "441--447",
journal = "Journal of Interferon Research",
issn = "0197-8357",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Antiproliferative activity of human interferons against ovarian cancer cells grown in human tumor stem cell assays

AU - Willson, J. K V

AU - Bittner, G.

AU - Borden, E. C.

PY - 1984

Y1 - 1984

N2 - Fresh biopsies from 14 of 22 (64%) ovarian carcinomas cultivated in the human tumor stem cell assay (HTSCA) were sensitive (> 70% inhibition in cell growth) to human interferons (HuIFNs). To achieve 70% inhibition of colony growth, 500 units/ml of a naturally produced IFN-α or IFN-αA were required in 71% of the sensitive specimens. The antiproliferative potencies of five IFNs were evaluated including two native α IFNs, two highly purified cloned subtypes of IFN-α, IFN-αD and IFN-αA, and one native fibroblast-derived beta interferon (IFN-β). The antiviral activity of the IFN-α as determined by a human cell target correlated with their relative antiproliferative action. IFN-αD had minimal inhibitory effect at the highest concentration tested, while three IFN-α with high antiviral activities were equivalent with respect to growth inhibition in the HTSCA. Although instability could not be eliminated as a contributing factor, IFN-β had significantly less growth inhibitory potency for cells from ovarian cancers when compared simultaneously with native IFN-α in the human tumor stem cell assay (HTSCA). Assuming direct antiproliferative effects are primary, future clinical trials evaluating IFN-α in ovarian cancer may require high titers of IFN.

AB - Fresh biopsies from 14 of 22 (64%) ovarian carcinomas cultivated in the human tumor stem cell assay (HTSCA) were sensitive (> 70% inhibition in cell growth) to human interferons (HuIFNs). To achieve 70% inhibition of colony growth, 500 units/ml of a naturally produced IFN-α or IFN-αA were required in 71% of the sensitive specimens. The antiproliferative potencies of five IFNs were evaluated including two native α IFNs, two highly purified cloned subtypes of IFN-α, IFN-αD and IFN-αA, and one native fibroblast-derived beta interferon (IFN-β). The antiviral activity of the IFN-α as determined by a human cell target correlated with their relative antiproliferative action. IFN-αD had minimal inhibitory effect at the highest concentration tested, while three IFN-α with high antiviral activities were equivalent with respect to growth inhibition in the HTSCA. Although instability could not be eliminated as a contributing factor, IFN-β had significantly less growth inhibitory potency for cells from ovarian cancers when compared simultaneously with native IFN-α in the human tumor stem cell assay (HTSCA). Assuming direct antiproliferative effects are primary, future clinical trials evaluating IFN-α in ovarian cancer may require high titers of IFN.

UR - http://www.scopus.com/inward/record.url?scp=0021162616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021162616&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 441

EP - 447

JO - Journal of Interferon Research

JF - Journal of Interferon Research

SN - 0197-8357

IS - 4

ER -